FOXO3 and hepatocellular carcinoma: It can sponge miR-605 to decrease its inhibition of FOXO3 protein, and increased FOXO3 expression targets the promoter region of ABCB1 to accelerate its expression, thereby increasing the anti-oxaliplatin ability of HCC (102).